Halozyme Therapeutics
HALO
₹4,654
Share price
0.24%
Change (1 day)
8.92%
Change (1 year)
Categories
Earnings for Halozyme Therapeutics (HALO)
Earnings in 2025 (TTM): ₹51.23 Billion
According to Halozyme Therapeutics's latest financial reports the company's current earnings are ₹1.08 Billion. In 2024 the company made an earning of ₹47.68 Billion, an increase over its 2023 earnings that were of ₹29.81 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Halozyme Therapeutics from 2002 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | ₹51.23 B | 7.44% |
| 2024 | ₹47.68 B | 59.94% |
| 2023 | ₹29.81 B | 39.94% |
| 2022 | ₹21.30 B | 0.16% |
| 2021 | ₹21.27 B | 92.2% |
| 2020 | ₹11.06 B | -278.96% |
| 2019 | -₹6.19 Billion | -9.45% |
| 2018 | -₹6.83 Billion | -229.51% |
| 2017 | ₹5.27 B | -160.48% |
| 2016 | -₹8.72 Billion | 216.03% |
| 2015 | -₹2.76 Billion | -52.86% |
| 2014 | -₹5.86 Billion | -18.09% |
| 2013 | -₹7.15 Billion | 55.88% |
| 2012 | -₹4.59 Billion | 169.94% |
| 2011 | -₹1.7 Billion | -63.44% |
| 2010 | -₹4.65 Billion | -7.19% |
| 2009 | -₹5.01 Billion | 15.91% |
| 2008 | -₹4.32 Billion | 83.89% |
| 2007 | -₹2.35 Billion | 78.1% |
| 2006 | -₹1.32 Billion | 16% |
| 2005 | -₹1.14 Billion | 45.24% |
| 2004 | -₹0.79 Billion | 682.42% |
| 2003 | -₹99.99 Million | 1659.12% |
| 2002 | -₹5.69 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 MannKind Corp MNKD | ₹2.84 B | -94.51% | 🇺🇸 USA |
 Eli Lilly LLY | ₹1.164 T | 2,148.25% | 🇺🇸 USA |
 Baxter BAX | -₹60.95 Billion | -217.70% | 🇺🇸 USA |
 Pfizer PFE | ₹885.08 B | 1,609.45% | 🇺🇸 USA |
 Sanofi SNY | ₹751.51 B | 1,351.47% | 🇫🇷 France |
 Johnson & Johnson JNJ | ₹2.345 T | 4,430.76% | 🇺🇸 USA |